U.S. regulators strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. The FDA said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s.
May 5, 2022 GMT
FILE - Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in Denver on Saturday, March 6, 2021. On Thursday, May 5, 2022, U.S. regulators strictly limited who can receive this vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA Officials Say Annual Covid-19 Shots May Be Needed In The FutureThe United States might need to update its Covid-19 vaccines each year, according to a trio of top US Food and Drug Administration officials, and 'a new normal' may include an annual Covid-19 vaccine alongside a seasonal flu shot.
Baca lebih lajut »
Annual COVID-19 shot could be necessary, FDA officials sayWe may need to get a COVID-19 vaccine every year, the same way we do with the flu shot.
Baca lebih lajut »
WHO: Nearly 15 million deaths associated with COVID-19The World Health Organization estimates that nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems in the past two years, more than double the official death toll of 6 million.
Baca lebih lajut »
Nearly 15 million deaths associated with COVID-19, says WHOThe World Health Organization estimates that nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems in the past two years, more than double the of…
Baca lebih lajut »
New COVID-19 variants emerge: BA.4, BA.5 likely reinfecting omicron survivorsThe rapid growth of BA.4 and BA.5 in South Africa has implications for a potential future surge in the U.S.
Baca lebih lajut »
COVID-19 cases could soon be at 'medium risk' level in ChicagoAs COVID-19 cases slowly rise in Chicago, city health officials say the city could be at 'medium risk' level in a matter of days.
Baca lebih lajut »